Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Plenary Scientific Session
  • Marquee Sessions and Lectures
  • Bookmark Icon
  • Superior event-free survival with ivosidenib plus intensive chemotherapy in newly diagnosed IDH1-mutated AML: Results from the phase 3 HOVON150/AMLSG29-18 trial...
    • Schedule
    Notes
  • MCCNO - Hall E
    Set Timezone

Generic 'disconnected' Message
Full Paper Title: Superior event-free survival with ivosidenib plus intensive chemotherapy in newly diagnosed IDH1-mutated AML: Results from the phase 3 HOVON150/AMLSG29-18 trial
Wouters:

Disclosure:

No relevant conflicts of interest to declare.
CME Status
Program
Main Session